Axa’s Xerium Technologies Inc (new) XRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-18,606
Closed -$79K 1452
2017
Q4
$79K Buy
+18,606
New +$81.8K ﹤0.01% 1333
2015
Q4
Sell
-8,492
Closed -$110K 1543
2015
Q3
$110K Sell
8,492
-22,130
-72% -$330K ﹤0.01% 1284
2015
Q2
$557K Buy
30,622
+11,604
+61% +$205K ﹤0.01% 1063
2015
Q1
$308K Sell
19,018
-2,511
-12% -$39.2K ﹤0.01% 1195
2014
Q4
$340K Buy
21,529
+8,699
+68% +$126K ﹤0.01% 1180
2014
Q3
$187K Sell
12,830
-6,091
-32% -$85.8K ﹤0.01% 1235
2014
Q2
$264K Hold
18,921
﹤0.01% 1193
2014
Q1
$304K Buy
18,921
+2,700
+17% +$44K ﹤0.01% 1152
2013
Q4
$267K Buy
16,221
+3,552
+28% +$46.3K ﹤0.01% 1175
2013
Q3
$147K Buy
+12,669
New +$146K ﹤0.01% 1166

Other funds holding XRM

Axa's XRM Position: Q1 2018 in Review

Axa sold out of Xerium Technologies Inc (new) (XRM) in Q1 2018, closing a stake of 18,606 shares — an estimated $79K sold.

Axa first reported a position in XRM in Q3 2013 and held it in 10 quarters. The position peaked at $557K in Q2 2015. 59 funds tracked by Wall St. Rank hold XRM as of Q1 2018.

  • Axa reported no remaining Xerium Technologies Inc (new) position as of Q1 2018 after selling out during the quarter.
  • Axa sold 18,606 Xerium Technologies Inc (new) shares in Q1 2018, an estimated $79K.
  • Axa first reported a position in Xerium Technologies Inc (new) in Q3 2013 and held it in 10 quarters.
  • Axa's Xerium Technologies Inc (new) position peaked at $557K in Q2 2015.
  • 59 funds tracked by Wall St. Rank held Xerium Technologies Inc (new) as of Q1 2018.

Based on Axa's 13F filing for Q1 2018, filed 14 May 2018.